摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

猫尿胺酸 | 471-09-0

中文名称
猫尿胺酸
中文别名
貓尿胺酸
英文名称
L-felinine
英文别名
S-(3-hydroxy-1,1-dimethylpropyl)-L-custeine;felinine;L-Felinin;L-Felinin, S-(3-Hydroxy-1,1-dimethyl-propyl)-cystein;L-S-(3-Hydroxy-1,1-dimethyl-propyl)-cystein;Felinine zwitterion;(2R)-2-azaniumyl-3-(4-hydroxy-2-methylbutan-2-yl)sulfanylpropanoate
猫尿胺酸化学式
CAS
471-09-0
化学式
C8H17NO3S
mdl
——
分子量
207.294
InChiKey
IFERABFGYYJODC-LURJTMIESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    162-164°C
  • 比旋光度:
    D25 -11.5° (c = 2.81 in water)
  • 溶解度:
    甲醇(微溶)、水(微溶)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.4
  • 重原子数:
    13
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    109
  • 氢给体数:
    3
  • 氢受体数:
    5

SDS

SDS:f5071788846cc169b7132c1c1b61ab08
查看

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Volatile Organic Sulfur-Containing Constituents in Poncirus trifoliata (L.) Raf. (Rutaceae)
    摘要:
    During our screening of plant materials to find new natural fragrance and flavor ingredients, we discovered two series of 3-sulfanylalkyl alkanoates in a peel extract of fruits of wild-growing Poncirus trifoliata (L.) Raf. (Rutaceae), a species closely related to Citrus. The two series belong to alkanoates of 3-methyl-3-sulfanylbutan-1-ol and 3-sulfanylhexan-1-ol, respectively, and thus are members of a family of natural molecules having in common a 1,3-positioned O,S moiety. The alkanoate residues comprise all even-numbered saturated fatty acids from C2 (acetate) to C18 (octadecanoate). Among the 20 sulfur-containing compounds identified, 14 are described for the first time as naturally occurring in a botanical species. Several cysteine-S-conjugates were synthesized as hypothetical precursors of the new volatile sulfur-containing constituents, where after S-(3-hydroxy-1,1-dimethylpropyl)-L-cysteine, S-[3-(acetyloxy)-1,1-dimethylpropyl]-L-cysteine, and S-[1-(2-hydroxyethyl)butyl]-L-cysteine were identified in the fruit peel. No cysteine-S-conjugates were detected in the fruit juice.
    DOI:
    10.1021/jf063453h
点击查看最新优质反应信息

文献信息

  • TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS
    申请人:LI Wei
    公开号:US20100227859A1
    公开(公告)日:2010-09-09
    The present teachings relate to compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, R4, X, and Y are as defined herein. The present teachings also provide methods of making the compounds of formula I and methods of inhibiting matrix metalloproteinases, in particular, MMP-12, that may be involved in pathological disorders found in mammals, including a human.
    目前的教导与式I的化合物有关:及其药用盐和酯,其中R1、R2、R3、R4、X和Y如本文所定义。目前的教导还提供了制备式I化合物的方法以及抑制基质蛋白酶的方法,特别是可能参与哺乳动物中发现的病理性疾病,包括人类。
  • [EN] PRODRUG COMPOSITIONS AND METHODS OF TREATMENT<br/>[FR] COMPOSITIONS DE PROMÉDICAMENT ET PROCÉDÉS DE TRAITEMENT
    申请人:AQUESTIVE THERAPEUTICS INC
    公开号:WO2021087359A1
    公开(公告)日:2021-05-06
    Pharmaceutical compositions include a prodrug of epinephrine are described.
    药物组合物包括表述的肾上腺素前药。
  • Methods for treating of skin conditions with retinoid double conjugate compounds
    申请人:US COSMECEUTECHS LLC
    公开号:US10123960B2
    公开(公告)日:2018-11-13
    A double conjugate molecule made of a retinoid, an organic acid, particularly an a-hydroxy acid, and an alcohol or acyl group, is provided which is useful in treating skin conditions, particularly aging. The retinoid, organic acid, and alcohol/acyl group are preferably linked via ester bonds.
    提供一种由视黄醇、有机酸(特别是α-羟基酸)和醇或酰基组成的双共轭分子,可用于治疗皮肤状况,特别是衰老。视黄醇、有机酸和醇/酰基组最好通过酯键连接。
  • Improvements in or relating to repellent compositions
    申请人:DALGETY U.K. LIMITED
    公开号:EP0280443A2
    公开(公告)日:1988-08-31
    A repellent composition e.g. for repelling deer comprises a synthetic blend of components which are characteristic of the acid fraction obtained by a Soxhlet extraction of lion faeces followed by separation into basic, neutral and acid fractions; and felinine. The composition may comprise saturated alkanoic acids with carbon atoms in the range of 3-20; saturated aliphatic alcohols with carbon atoms in the range 14-16; various compounds containing primary or secondary amino groups and having carbon atoms in the range 3-9; a fermented egg product; a bittering agent and an adhesive agent.
    一种驱避剂组合物,例如用于驱赶鹿的组合物,由多种成分合成混合而成,这些成分的特征是通过对狮子粪便进行索氏提取,然后分离成碱性、中性和酸性馏分而得到的酸性馏分;以及猫科动物碱。 该组合物可包括碳原子范围在 3-20 之间的饱和烷酸;碳原子范围在 14-16 之间的饱和脂肪醇;含有伯基或仲基且碳原子范围在 3-9 之间的各种化合物;一种发酵蛋制品;一种苦味剂和一种粘合剂。
  • NMR imaging with Mn(II) coordination compositions
    申请人:SALUTAR, INC.
    公开号:EP0308983A2
    公开(公告)日:1989-03-29
    Enhanced T₁ and T₂ relaxation in NMRI is obtained with solutions of non-chelate coordination compounds of the formula: [Mn(II)(H₂O)mA1nA2oA3pA4q]+a(Y,Zr)-a In the formula, A1, A2, A3 and A4 are the same of different amino-substituted carboxylic acid groups having from 2 to 18 carbons; Y and Z are each the same or a different anion of a pharmaceutically acceptable inorganic acid or an organic carboxylic acid having from 2 to 18 carbons; a is valence of the ions; m, n, o, p, and q are each 1 or 0, (m + n + o + p + q) = 4, and (n + o + p + q) is preferably from 1 to 3; and r is 1, and if Y is a multivalent anion, r is 0 or 1. The solution has a pH within the range of from 4 to 9.5, preferably from 5 to 7, and optimally from 5 to 6.5, and for parenteral administration, a coordination compound concentration of from 0.5 to 4.0 wt%. Preferably, n is from 1 to 3, optimally from 2-4, and most optimally from 2 to 3, and Y and Z are monovalent. For example Y is preferably an anion of an aliphatic carboxylic acid having from 2 to 6 carbons such as acetic, propionic, n-butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid or gluconic acid, and Z is an inorganic anion such as chloride or sulfate. A1, A2, A3 and A4 are preferably α-amino acids having from 2 to 6 carbons such as glycine.
    利用式中的非螯合物配位化合物溶液,可以增强 NMRI 中的 T₁ 和 T₂ 弛豫: [Mn(II)(H₂O)mA1nA2oA3pA4q]+a(Y,Zr)-a 式中 A1、A2、A3 和 A4 是具有 2 至 18 个碳原子的相同或不同的基取代的羧酸基团; Y 和 Z 分别是相同或不同的药学上可接受的无机酸阴离子或具有 2 至 18 个碳原子的有机羧酸阴离子; a 是离子的化合价; m、n、o、p 和 q 各为 1 或 0,(m + n + o + p + q)= 4,(n + o + p + q)最好为 1 至 3;以及 r 为 1,如果 Y 是多价阴离子,则 r 为 0 或 1。 溶液的 pH 值范围为 4 至 9.5,优选 5 至 7,最佳为 5 至 6.5,对于肠外给药,配位化合物的浓度为 0.5 至 4.0 wt%。n 最好为 1 至 3,最佳为 2 至 4,最理想为 2 至 3,Y 和 Z 为一价。例如,Y 最好是具有 2 至 6 个碳原子的脂肪族羧酸的阴离子,如乙酸丙酸、正丁酸异丁酸戊酸异戊酸特戊酸葡萄糖酸,Z 是无机阴离子,如化物或硫酸盐。A1、A2、A3 和 A4 最好是具有 2 至 6 个碳原子的 α-氨基酸,如甘酸。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸